Allocations
HSBC Asset Management has held the final closing of its third directly-managed secondaries fund, Private Equity Opportunities III, which launched in December 2022, with total commitments of around $738 million, bringing total commitments across HSBC AM’s secondaries program to a combined $3.2 billion.
Fidelio Capital has closed its third flagship fund (Fidelio III), with total capital commitments in excess of the fund’s €1 billion target, more than triple the size of its predecessor fund, Fidelio II, which closed in 2018.Â
Vertex Ventures HC has launched its third and largest fund, the $200 million Fund III, which will be deployed to support life sciences and medical technology companies “aiming to drive innovation and improve patient outcomes”.
Buyout funds continued to display resilient performance during a turbulent Q1 of 2023, according to research by Neuberger Berman, with small and mid-cap buyout funds, the largest asset class in the sample, up approximately 3% on average over the quarter.
IQ Capital, a London-based deep tech venture capital firm, continues to strengthen its senior team with the promotion of two new partners – Archie Muirhead and Alex Wilson, who join existing general partners Kerry Baldwin, Max Bautin, Simon Hirtzel and Ed Stacey.
Chrysalix Venture Capital has held the first close of its fifth fund, the Carbon Neutrality Fund, which will invest in early-stage companies developing technologies to enable carbon neutrality for industries such as energy, mining, transport, chemicals, building materials like steel and cement, and forestry.
French group Ardian has raised more than $20 billion, including $6 billion from the Abu Dhabi Investment Authority, for a new secondary fund that will target the acquisition of stakes in private equity funds from investors, according to a report by The Financial Times.
Oaktree Capital Management has held the close of its Life Sciences Lending Fund – its first dedicated life sciences fund – and related vehicles, oversubscribed with total capital commitments in excess of $2.3 billion.Â
Stone-Goff Partners, a growth-oriented private equity firm focused on tech-driven B2B service companies, has held the final closing of Stone-Goff Partners IV at $175 million, having secured significant increases in commitments from existing investors as well new institutional investors.Â
Harmonix Management, a venture capital investment firm focused on investments in science-driven startups, has launched fundraising for its third fund, which will will continue the firm’s strategy of focusing on healthcare, life sciences, and deep tech investments.
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
